Short Squeeze - CMMB
Updated
Idea for Chemomab Therapeutics Ltd.:
- 131% borrow fee for shares. 47 shares available for borrow, according to iborrowdesk.
- Bottom of Risk Range:
- S3 Filing Sales Agreement with Cantor Fitzgerald & Co. dated Apr 30, 2021. fintel.io/doc/sec-chemomab-therapeutics-ltd-ex12-2021-april-30-18747-818
- Cantor Fitzgerald assigned overweight rating on CMMB and raised price target to $45. marketbeat.com/ratings/by-issuer/cantor-fitzgerald-stock-recommendations/
- Good short squeeze material.
- Non Optionable.
Bought the shares $16.69
Expect share dilution $40-$50
GLHF
- DPT
- 131% borrow fee for shares. 47 shares available for borrow, according to iborrowdesk.
- Bottom of Risk Range:
- S3 Filing Sales Agreement with Cantor Fitzgerald & Co. dated Apr 30, 2021. fintel.io/doc/sec-chemomab-therapeutics-ltd-ex12-2021-april-30-18747-818
- Cantor Fitzgerald assigned overweight rating on CMMB and raised price target to $45. marketbeat.com/ratings/by-issuer/cantor-fitzgerald-stock-recommendations/
- Good short squeeze material.
- Non Optionable.
Bought the shares $16.69
Expect share dilution $40-$50
GLHF
- DPT
Order cancelled
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.